182 related articles for article (PubMed ID: 36070465)
1. Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation.
Berge-Seidl S; Nielsen NV; Rodriguez Alfonso AA; Etscheid M; Kandanur SPS; Haug BE; Stensland M; Thiede B; Karacan M; Preising N; Wiese S; Ständker L; Declerck PJ; Løset GÅ; Kanse SM
ACS Chem Biol; 2022 Sep; 17(9):2631-2642. PubMed ID: 36070465
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
Kara E; Manna D; Løset GÅ; Schneider EL; Craik CS; Kanse S
Thromb Haemost; 2017 Aug; 117(9):1750-1760. PubMed ID: 28726978
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice.
Artunc F; Bohnert BN; Schneider JC; Staudner T; Sure F; Ilyaskin AV; Wörn M; Essigke D; Janessa A; Nielsen NV; Birkenfeld AL; Etscheid M; Haerteis S; Korbmacher C; Kanse SM
Pflugers Arch; 2022 Feb; 474(2):217-229. PubMed ID: 34870751
[TBL] [Abstract][Full Text] [Related]
4. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.
Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J
Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747
[TBL] [Abstract][Full Text] [Related]
5. Cellular effects of factor VII activating protease (FSAP).
Byskov K; Etscheid M; Kanse SM
Thromb Res; 2020 Apr; 188():74-78. PubMed ID: 32087413
[TBL] [Abstract][Full Text] [Related]
6. Design and Characterization of a New pVII Combinatorial Phage Display Peptide Library for Protease Substrate Mining Using Factor VII Activating Protease (FSAP) as Model.
Kara E; Nielsen NV; Eggertsdottir B; Thiede B; Kanse SM; Løset GÅ
Chembiochem; 2020 Jul; 21(13):1875-1884. PubMed ID: 32180321
[TBL] [Abstract][Full Text] [Related]
7. Factor VII Activating Protease (FSAP) and Its Importance in Hemostasis-Part I: FSAP Structure, Synthesis and Activity Regulation: A Narrative Review.
Kwiatkowska I; Żekanowska E; Lattanzi S; Alexandre AM; Kister-Kowalska A; Słomka A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982544
[TBL] [Abstract][Full Text] [Related]
8. Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs).
Grasso S; Neumann A; Lang IM; Etscheid M; von Köckritz-Blickwede M; Kanse SM
Thromb Res; 2018 Jan; 161():36-42. PubMed ID: 29178989
[TBL] [Abstract][Full Text] [Related]
9. Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models.
Kim JY; Manna D; Etscheid M; Leergaard TB; Kanse SM
FASEB J; 2022 Oct; 36(10):e22564. PubMed ID: 36165219
[TBL] [Abstract][Full Text] [Related]
10. Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis.
Etscheid M; Hanschmann KM; Sandset PM; Kanse SM
Thromb Res; 2022 Dec; 220():24-34. PubMed ID: 36265411
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent activity-based probe for the selective detection of Factor VII activating protease (FSAP) in human plasma.
Rut W; Nielsen NV; Czarna J; Poreba M; Kanse SM; Drag M
Thromb Res; 2019 Oct; 182():124-132. PubMed ID: 31479940
[TBL] [Abstract][Full Text] [Related]
12. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
Kanse SM; Parahuleva M; Muhl L; Kemkes-Matthes B; Sedding D; Preissner KT
Thromb Haemost; 2008 Feb; 99(2):286-9. PubMed ID: 18278176
[TBL] [Abstract][Full Text] [Related]
13. The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).
Roemisch J; Feussner A; Nerlich C; Stoehr HA; Weimer T
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):433-41. PubMed ID: 12138371
[TBL] [Abstract][Full Text] [Related]
14. The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2).
Roedel EK; Schwarz E; Kanse SM
J Biol Chem; 2013 Mar; 288(10):7193-203. PubMed ID: 23341458
[TBL] [Abstract][Full Text] [Related]
15. Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency.
Gramstad OR; Kandanur SPS; Etscheid M; Nielsen EW; Kanse SM
Mol Immunol; 2022 Feb; 142():95-104. PubMed ID: 34973499
[TBL] [Abstract][Full Text] [Related]
16. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease.
Muhl L; Galuska SP; Oörni K; Hernández-Ruiz L; Andrei-Selmer LC; Geyer R; Preissner KT; Ruiz FA; Kovanen PT; Kanse SM
FEBS J; 2009 Sep; 276(17):4828-39. PubMed ID: 19664058
[TBL] [Abstract][Full Text] [Related]
17. Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP).
Etscheid M; Subramaniam S; Lochnit G; Zabczyk M; Undas A; Lang IM; Hanschmann KM; Kanse SM
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3397-3406. PubMed ID: 30076961
[TBL] [Abstract][Full Text] [Related]
18. A Positively Charged Surface Triggers Coagulation Activation Through Factor VII Activating Protease (FSAP).
Sperling C; Maitz MF; Grasso S; Werner C; Kanse SM
ACS Appl Mater Interfaces; 2017 Nov; 9(46):40107-40116. PubMed ID: 29091393
[TBL] [Abstract][Full Text] [Related]
19. Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.
Sidelmann JJ; Skouby SO; Kluft C; Winkler U; Vitzthum F; Schwarz H; Gram J; Jespersen J
Thromb Res; 2011 Nov; 128(5):e67-72. PubMed ID: 21737124
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor pathway inhibitor is an inhibitor of factor VII-activating protease.
Stephan F; Dienava-Verdoold I; Bulder I; Wouters D; Mast AE; Te Velthuis H; Aarden LA; Zeerleder S
J Thromb Haemost; 2012 Jun; 10(6):1165-71. PubMed ID: 22449009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
